Loading...
Fetching results...
0 items found

The content in the Resource Centre is not accredited.

118: Spironolactone use is associated with lower risk of prostate cancer

Speaker
Dr. K. (Kerri) Beckmann
Authors
Beckmann K.1, Garmo H.2, Lindahl B.3, Holmberg L.1, Stattin P.4, Adolfsson J.5, Cruickshank K.6, Van Hemelrijck M.1
Institutions
1Kings College London, Dept. of Translational Oncology and Urology Research (TOUR), London, United Kingdom, 2Uppsala University, Regional Cancer Center, Uppsala, Sweden, 3Uppsala University, Uppsala Clinical Research Center, Uppsala, Sweden, 4Uppsala University, Dept. of Surgical Sciences, Uppsala, Sweden, 5Karolinska Institutet, CLINTEC-Department, Stockholm, Sweden, 6Kings College London, Dept. of Nutritional Studies, London, United Kingdom
Event
35th Annual EAU Congress - Virtual (EAU20V)
Date
17 July 2020
Topic
Prostate Cancer, localised - Diagnosis, Epidemiology